The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells.

Breast Cancer Res · 2019 · PMC6480921 · PMID 31014367

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp < 0.06so close (0.05 < p ≤ 0.1)

Patients with high-level IL-6 plus PTGER2 plus PTGER4 showed a trend to reduced distant metastasis-free survival (DMSF, p < 0.06 , Fig. 7 d), and a significant reduction in OS ( p = 0.0045 , Fig. 7 e), compared to patients with low-level IL-6 plus PTGER2 plus PTGER4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.